<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".01" citation="COMAR 10.34.19.01" title_num="10" subtitle_num="34" chapter_num="19" heading="Scope.">
  <text>This chapter applies to a licensed pharmacy in Maryland engaging in:</text>
  <paragraph num="A.">
    <text>Compounding or mixing sterile prescription solutions or suspensions to be administered parenterally or by irrigation, inhalation, or intraocular routes; and</text>
  </paragraph>
  <paragraph num="B.">
    <text>Compounding of radiopharmaceuticals, except where U.S. Pharmacopeia (USP) General Chapter 797 Pharmaceutical Compounding — Sterile Preparations addresses radiopharmaceuticals, U.S. Pharmacopeia (USP) Chapter 821 Radioactivity, and U.S. Pharmacopeia (USP) Chapter 823 Radiopharmaceuticals for Positron Emission Tomography — Compounding would apply.</text>
  </paragraph>
</regulation>